10X Genomics
TXGTXG · Stock Price
Historical price data
Overview
10X Genomics' mission is to master biology to advance human health by providing essential infrastructure for modern biological research. The company has achieved market leadership with its Chromium, Xenium, and Visium platforms, which are cited in over 10,000 publications and used by thousands of researchers globally. Its strategy focuses on expanding its integrated hardware, software, and chemistry ecosystem to drive adoption in both research and translational markets, including pharmaceutical drug development and AI-driven cell modeling.
Technology Platform
Integrated platforms for single-cell and spatial genomics analysis, utilizing proprietary microfluidic partitioning (GEM technology), in situ hybridization, and whole-transcriptome capture to profile biology at cellular and subcellular resolution.
Funding History
3Company Timeline
Founded in Pleasanton, United States
Series A: $55.0M
Series B: $55.0M
IPO — $350.0M